Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1984 Jan;25(1):53–57. doi: 10.1128/aac.25.1.53

Combined interferon-alpha 2, rimantadine hydrochloride, and ribavirin inhibition of influenza virus replication in vitro.

F G Hayden, A N Schlepushkin, N L Pushkarskaya
PMCID: PMC185434  PMID: 6703684

Abstract

Recombinant DNA-produced human interferon-alpha 2 inhibited the replication of influenza A and B viruses in primary rhesus monkey kidney cells (RMK). Human interferon-alpha 2 interacted additively or synergistically with rimantadine hydrochloride or ribavirin in reducing the yield of clinical isolates of either H3N2 or H1N1 subtype influenza A viruses. The combination of human interferon-alpha 2 and ribavirin also inhibited the replication of an influenza B virus to a greater extent than either single agent. In addition to drug concentration, the virus inoculum and duration of culture were important variables in determining the degree of inhibition. Single drugs or combinations did not significantly inhibit the growth of uninfected RMK cells, which indicated that the observed interactions with respect to antiviral activity were not due to cell cytotoxicity.

Full text

PDF
53

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARON S., ISAACS A. Absence of interferon in lungs fom fatal cases of influenza. Br Med J. 1962 Jan 6;1(5270):18–20. doi: 10.1136/bmj.1.5270.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Browne M. J., Moss M. Y., Boyd M. R. Comparative activity of amantadine and ribavirin against influenza virus in vitro: possible clinical relevance. Antimicrob Agents Chemother. 1983 Mar;23(3):503–505. doi: 10.1128/aac.23.3.503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bryson Y. J., Kronenberg L. H. Combined antiviral effects of interferon, adenine, arabinoside, hypoxanthine arabinoside, and adenine arabinoside-5'-monophosphate in human fibroblast cultures. Antimicrob Agents Chemother. 1977 Feb;11(2):299–306. doi: 10.1128/aac.11.2.299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dolin R., Reichman R. C., Madore H. P., Maynard R., Linton P. N., Webber-Jones J. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med. 1982 Sep 2;307(10):580–584. doi: 10.1056/NEJM198209023071002. [DOI] [PubMed] [Google Scholar]
  5. Galegov G. A., Pushkarskaya N. L., Obrosova-Serova N. P., Zhdanov V. M. Combined action of ribovirin and rimantadine in experimental myxovirus infection. Experientia. 1977 Jul 15;33(7):905–906. doi: 10.1007/BF01951273. [DOI] [PubMed] [Google Scholar]
  6. Green J. A., Charette R. P., Yeh T. J., Smith C. B. Presence of interferon in acute- and convalescent-phase sera of humans with influenza or influenza-like illness of undetermined etiology. J Infect Dis. 1982 Jun;145(6):837–841. doi: 10.1093/infdis/145.6.837. [DOI] [PubMed] [Google Scholar]
  7. Hayden F. G., Cote K. M., Douglas R. G., Jr Plaque inhibition assay for drug susceptibility testing of influenza viruses. Antimicrob Agents Chemother. 1980 May;17(5):865–870. doi: 10.1128/aac.17.5.865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hayden F. G., Douglas R. G., Jr, Simons R. Enhancement of activity against influenza viruses by combinations of antiviral agents. Antimicrob Agents Chemother. 1980 Oct;18(4):536–541. doi: 10.1128/aac.18.4.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hayden F. G., Gwaltney J. M., Jr Intranasal interferon alpha 2 for prevention of rhinovirus infection and illness. J Infect Dis. 1983 Sep;148(3):543–550. doi: 10.1093/infdis/148.3.543. [DOI] [PubMed] [Google Scholar]
  10. Hayden F. G., Hall W. J., Douglas R. G., Jr Therapeutic effects of aerosolized amantadine in naturally acquired infection due to influenza A virus. J Infect Dis. 1980 May;141(5):535–542. doi: 10.1093/infdis/141.5.535. [DOI] [PubMed] [Google Scholar]
  11. Hayden F. G., Mills S. E., Johns M. E. Human tolerance and histopathologic effects of long-term administration of intranasal interferon-alpha 2. J Infect Dis. 1983 Nov;148(5):914–921. doi: 10.1093/infdis/148.5.914. [DOI] [PubMed] [Google Scholar]
  12. Hayden F. G., Zylidnikov D. M., Iljenko V. I., Padolka Y. V. Comparative therapeutic effect of aerosolized and oral rimantadine HCl in experimental human influenza A virus infection. Antiviral Res. 1982 Aug;2(3):147–153. doi: 10.1016/0166-3542(82)90016-x. [DOI] [PubMed] [Google Scholar]
  13. Isomura S., Ichikawa T., Miyazu M., Naruse H., Shibata M., Imanishi J., Matsuo A., Kishida T., Karaki T. The preventive effect of human interferon-alpha on influenza infection; modification of clinical manifestations of influenza in children in a closed community. Biken J. 1982 Sep;25(3):131–137. [PubMed] [Google Scholar]
  14. Jao R. L., Wheelock E. F., Jackson G. G. Production of interferon in volunteers infected with Asian influenza. J Infect Dis. 1970 Apr;121(4):419–426. doi: 10.1093/infdis/121.4.419. [DOI] [PubMed] [Google Scholar]
  15. Knight V., McClung H. W., Wilson S. Z., Waters B. K., Quarles J. M., Cameron R. W., Greggs S. E., Zerwas J. M., Couch R. B. Ribavirin small-particle aerosol treatment of influenza. Lancet. 1981 Oct 31;2(8253):945–949. doi: 10.1016/s0140-6736(81)91152-1. [DOI] [PubMed] [Google Scholar]
  16. Lavrov S. V., Eremkina E. I., Orlova T. G., Galegov G. A., Soloviev V. D., Zhdanov V. M. Combined inhibition of influenza virus reproduction in cell culture using interferon and amantadine. Nature. 1968 Mar 2;217(5131):856–857. doi: 10.1038/217856a0. [DOI] [PubMed] [Google Scholar]
  17. Murphy B. R., Baron S., Chalhub E. G., Uhlendorf C. P., Chanock R. M. Temperature-sensitive mutants of influenza virus. IV. Induction of interferon in the nasopharynx by wild-type and a temperature-sensitive recombinant virus. J Infect Dis. 1973 Oct;128(4):488–493. doi: 10.1093/infdis/128.4.488. [DOI] [PubMed] [Google Scholar]
  18. Richman D. D., Murphy B. R., Baron S., Uhlendorf C. Three strains of influenza A virus (H3N2): interferon sensitivity in vitro and interferon production in volunteers. J Clin Microbiol. 1976 Mar;3(3):223–226. doi: 10.1128/jcm.3.3.223-226.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Schellekens H., de Reus A., Bolhuis R., Fountoulakis M., Schein C., Ecsödi J., Nagata S., Weissmann C. Comparative antiviral efficiency of leukocyte and bacterially produced human alpha-interferon in rhesus monkeys. Nature. 1981 Aug 20;292(5825):775–776. doi: 10.1038/292775a0. [DOI] [PubMed] [Google Scholar]
  20. Schellekens H., van Eerd P. M., de Reus A., Weck P. K., Stebbing N. Antiviral and side effects of interferons produced by recombinant DNA techniques as tested in rhesus monkeys. Antiviral Res. 1982 Oct;2(5):313–318. doi: 10.1016/0166-3542(82)90054-7. [DOI] [PubMed] [Google Scholar]
  21. Schinazi R. F., Peters J., Williams C. C., Chance D., Nahmias A. J. Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in mice. Antimicrob Agents Chemother. 1982 Sep;22(3):499–507. doi: 10.1128/aac.22.3.499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Smith C. B., Charette R. P., Fox J. P., Cooney M. K., Hall C. E. Lack of effect of oral ribavirin in naturally occurring influenza A virus (H1N1) infection. J Infect Dis. 1980 May;141(5):548–554. doi: 10.1093/infdis/141.5.548. [DOI] [PubMed] [Google Scholar]
  23. Solov'ev V. D. The results of controlled observations on the prophylaxis of influenza with interferon. Bull World Health Organ. 1969;41(3):683–688. [PMC free article] [PubMed] [Google Scholar]
  24. Van Voris L. P., Betts R. F., Hayden F. G., Christmas W. A., Douglas R. G., Jr Successful treatment of naturally occurring influenza A/USSR/77 H1N1. JAMA. 1981 Mar 20;245(11):1128–1131. doi: 10.1001/jama.245.11.1128. [DOI] [PubMed] [Google Scholar]
  25. Wilson S. Z., Knight V., Wyde P. R., Drake S., Couch R. B. Amantadine and ribavirin aerosol treatment of influenza A and B infection in mice. Antimicrob Agents Chemother. 1980 Apr;17(4):642–648. doi: 10.1128/aac.17.4.642. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES